MLLT3 and leukemia: Furthermore, Snai2 knock out was able to reduce the ability of MLL-AF9 and NUP98-HoxA9 oncogenes to transform mouse HSCs in vivo, while limiting dilution assays demonstrated reduced LSC/LIC frequencies in Snai2 knockout MLL-AF9 leukemia.